CAM
ALDR
Cormorant Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-900,000
| Closed | -$11M | – | 57 |
|
|
2017
Q3 | $11M | Hold |
900,000
| – | – | 1.95% | 18 |
|
|
2017
Q2 | $10.3M | Sell |
900,000
-198,205
| -18% | -$2.27M | 1.71% | 20 |
|
|
2017
Q1 | $22.8M | Sell |
1,098,205
-483,399
| -31% | -$10.1M | 3.32% | 10 |
|
|
2016
Q4 | $32.9M | Sell |
1,581,604
-107,467
| -6% | -$2.24M | 4.43% | 4 |
|
|
2016
Q3 | $55.4M | Hold |
1,689,071
| – | – | 6.1% | 1 |
|
|
2016
Q2 | $42.2M | Buy |
1,689,071
+191,596
| +13% | +$4.78M | 5.98% | 1 |
|
|
2016
Q1 | $36.7M | Buy |
1,497,475
+740,000
| +98% | +$18.1M | 5.52% | 1 |
|
|
2015
Q4 | $25M | Hold |
757,475
| – | – | 2.99% | 9 |
|
|
2015
Q3 | $24.8M | Hold |
757,475
| – | – | 3.96% | 6 |
|
|
2015
Q2 | $40.1M | Buy |
757,475
+440,000
| +139% | +$23.3M | 5.33% | 4 |
|
|
2015
Q1 | $9.16M | Buy |
317,475
+67,475
| +27% | +$1.95M | 1.42% | 21 |
|
|
2014
Q4 | $7.27M | Buy |
250,000
+100,000
| +67% | +$2.91M | 1.12% | 26 |
|
|
2014
Q3 | $1.9M | Hold |
150,000
| – | – | 0.39% | 52 |
|
|
2014
Q2 | $3.01M | Buy |
+150,000
| New | +$3.01M | 0.8% | 41 |
|